Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 5,113 shares at $38.12 ($196K) on 2017-09-13, disclosed to the SEC on 2017-09-14.
Scheduled sale ($196k) by SVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.31 | 4,605 | $176K | 89.8% |
| 2 | $39.39 | 500 | $20K | 10.0% |
| 3 | $38.12 | 8 | $305 | 0.2% |
| Total | $38.42 avg | 5,113 | $196K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |